Moreover, analyses of human cancers samples obtained from patients diagnosed with the Li-Fraumeni syndrome have shown that the remaining wild-type TP53 allele is not always lost, proposing that haploinsufficiency of TP53 may be enough for tumor initiation [50]. The gene discussed is TP53; the disease is Li-Fraumeni syndrome.